Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sagopilone in second-line NSCLC
NCT00160069Phase 2Completed
- Sponsor
- Bayer
- Start
- Aug 2005
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sagopilone in non-small cell lung cancer (NSCLC), sponsored by Bayer. Started Aug 2005; status: completed.
02
Drugs
sagopilone
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00160069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160069.